Te?ted Oy, a diagnostics company, is revolutionizing the way complex diseases are diagnosed. Every couple of seconds someone on earth is infected due to a tick bite and projections estimate that by 2050 35% of the global population will be infected by tick-borne diseases. Te?ted has developed a diagnostics kit that can simultaneously test up to 15 different microbes associated with tick-borne diseases. It is a multifunctional assay, as the test can both determine the disease as well as the stage of the illness.
Te?ted is ISO 13485:2016 certified and their products TICKPLEX® PLUS, TICKPLEX® BASIC, and TICKPLEX® ANALYZE are CE and IVD certified. These first products are already available in Austria, Canada, Germany, Switzerland and the Netherlands and used to diagnose patients faster and more efficiently.
“We were invited to join NOME after winning the NOME Annual Meeting & Startup Competition. The reason for us participating in the competition was to get access to very competent and experienced mentors. With the help of our NOME mentors, we want to explore reimbursement and market entry strategies as this will be crucial for the development of Te?ted.”
Based on the research from CEO Leona Gilbert’s research group at the University of Jyväskylä, Leona Gilbert has gathered a strong team to commercialize their diagnostic products. Te?ted Oy is located in Jyväskylä, Finland, and joined NOME in 2018.